Literature DB >> 17571234

Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.

Christina Kratzer1, Wolfgang Graninger, Karin Macfelda, Astrid Buxbaum, Apostolos Georgopoulos.   

Abstract

INTRODUCTION: Non-typeable Haemophilus influenzae (NTHi) is a major bacterial pathogen of community-acquired respiratory tract infection and is usually found extracellularly, although studies have revealed that NTHi may possess the ability to invade human epithelial cells where it is then protected against attack by the local immune system and partly against the effect of antibiotics. The aim of the present study was to assess the ability of ampicillin, azithromycin, telithromycin, ciprofloxacin and moxifloxacin, five antibiotics in common clinical use, to kill NTHi within bronchial epithelial cells.
METHODS: Confluent human bronchial epithelial cells were infected with NTHi 77, a particularly invasive clinical strain. Extracellular bacterial cells were killed with gentamicin and the intracellular bacteria were incubated with antibiotics at concentrations of 1 mg/l or 10 mg/l for 4 h or 8 h. Viable intracellular bacteria were counted after lysis of the epithelial cells.
RESULTS: With the exception of ampicillin, all the antibiotics caused significant reduction of intracellular bacteria at concentrations of 10 mg/l and exposure for 4 h or at 1 mg/l for 8 h. At 1 mg/l, moxifloxacin eliminated 94% of intracellular NTHi after 4 h and 98% after 8 h; ciprofloxacin, azithromycin and telithromycin only achieved killing indices below 75 after 4 h but 86-90% killing after 8 h. At 10 mg/l, moxifloxacin, ciprofloxacin, telithromycin and azithromycin were able to achieve 99.7%, 96.3%, 86.7% and 74.7% eradication of intracellular bacteria, respectively, after exposure for 4 h.
CONCLUSION: These results demonstrate the rapid antibacterial efficacy of moxifloxacin against intracellular NTHi in vitro. Moxifloxacin, which combines high extracellular and intracellular activities, could be an important tool in the treatment of recurrent respiratory tract infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571234     DOI: 10.1007/s00508-007-0784-5

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  26 in total

1.  Activities of antimicrobial agents against intracellular pneumococci.

Authors:  G L Mandell; E J Coleman
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  Haemophilus influenzae localized in epithelial cell layers is shielded from antibiotics and antibody-mediated bactericidal activity.

Authors:  M van Schilfgaarde; P Eijk; A Regelink; P van Ulsen; V Everts; J Dankert; L van Alphen
Journal:  Microb Pathog       Date:  1999-05       Impact factor: 3.738

3.  Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor.

Authors:  W E Swords; B A Buscher; K Ver Steeg Ii; A Preston; W A Nichols; J N Weiser; B W Gibson; M A Apicella
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

4.  An unrecognized epidemic of Mycoplasma pneumoniae infection in Vienna.

Authors:  Florian Daxboeck; Claudia C Bauer; Ojan Assadian; Gerold Stanek
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

5.  Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells.

Authors:  A Pascual; I García; S Ballesta; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

6.  The penetration of ciprofloxacin into bronchial mucosa, lung parenchyma, and pleural tissue after intravenous administration.

Authors:  M Dan; K Torossian; D Weissberg; R Kitzes
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Andrew T Schiffmacher; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2004-04-29       Impact factor: 21.405

8.  Group A streptococci efficiently invade human respiratory epithelial cells.

Authors:  D LaPenta; C Rubens; E Chi; P P Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

9.  Microbioassay of antimicrobial agents.

Authors:  H J Simon; E J Yin
Journal:  Appl Microbiol       Date:  1970-04

10.  Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.

Authors:  Cristina Seral; Françoise Van Bambeke; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

View more
  3 in total

1.  Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection.

Authors:  Begoña Euba; Javier Moleres; Cristina Viadas; Montserrat Barberán; Lucía Caballero; María-Jesús Grilló; José Antonio Bengoechea; Juan Pablo de-Torres; Josefina Liñares; José Leiva; Junkal Garmendia
Journal:  Antimicrob Agents Chemother       Date:  2015-02-23       Impact factor: 5.191

2.  Multi-species bacterial biofilm and intracellular infection in otitis media.

Authors:  Ruth B Thornton; Paul J Rigby; Selma P Wiertsema; Pierre Filion; Jennifer Langlands; Harvey L Coates; Shyan Vijayasekaran; Anthony D Keil; Peter C Richmond
Journal:  BMC Pediatr       Date:  2011-10-24       Impact factor: 2.125

3.  Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.

Authors:  S Sethi; A Anzueto; M Miravitlles; P Arvis; J Alder; D Haverstock; M Trajanovic; R Wilson
Journal:  Infection       Date:  2015-09-14       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.